Kristen R. Taylor Meadows,Brett Skolnick,Deepak Dalvie
申请号：
US16611451
公开号：
US20200085795A1
申请日:
2018.05.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods of treating conditions for which S1P-mediated neuroprotection is medically indicated, comprising administering to a subject in need thereof an agonist of the sphingosine 1-phosphate receptor (S1P receptor)； such as a compound having the following structure (See Formula 1): or a pharmaceutically acceptable salt, stereoisomer, homolog, hydrate or solvate thereof.
